Condition: Depressive Disorder, Major · Sponsor: GrayMatters Health Ltd.
The purpose of this research is to learn more about a new treatment for individuals with Major Depressive Disorder (MDD) with heightened symptoms of anhedonia (i.e. loss of pleasure or interest in activities). The treatment is called Prism, and it is a software device intended for a novel form of neurofeedback training to be used in a clinic setting. During this study, the subject will use different techniques to measure brain activities, including magnetic resonance imaging (MRI) and electroencephalography (EEG).
This description comes directly from the study's public registry record.
Adar Shani, MSc · +972-54-2347770 · adar@graymatters-health.com
Jennifer Yarden, PhD · +972-52-4897823 · jennifer@graymatters-health.com
Always discuss trial participation with your own doctor first.
| Butler Hospital | Providence, Rhode Island, United States | Recruiting |
| Houston Center For Advanced Psychiatric Treatment | Houston, Texas, United States | Recruiting |
| Sheba Medical Center | Ramat Gan, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06982820